Stephen M Weber, Brian W Downs, Mario B J Ferraz, Tom D Wang, Ted A Cook
{"title":"Facial resurfacing with coblation technology.","authors":"Stephen M Weber, Brian W Downs, Mario B J Ferraz, Tom D Wang, Ted A Cook","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To describe our experience with coblation technology for facial resurfacing</p><p><strong>Methods: </strong>Retrospective chart review of all patients treated with coblation at our institution</p><p><strong>Results: </strong>Twenty-four patients (22 female) underwent a total of 29 coblation procedures for aging face (n = 21) or acne scarring (n = 3). The perioral region was the most frequently treated aesthetic subunit (n = 14), followed by the lower eyelid (n = 7). Five patients underwent full-face coblation. Three patients underwent a second coblation procedure for aging face while a single patient with severe acne scarring underwent 3 procedures. Repeat coblation was delayed at least 5 months (mean, 9 months). Seventeen coblation procedures (59%) were performed concurrently with procedures including, but not limited to, injection treatment, rhinoplasty, blepharoplasty, or combined face/necklift; no adverse events occurred. Seven procedures, including a full-face coblation, were performed in the office under local anesthesia and oral sedation without any adverse events. Mean follow-up was 6 months (range, 1 week to 24 months). No complications were observed. All patients were satisfied with the results after their final coblation treatment.</p><p><strong>Conclusions: </strong>Facial coblation is a safe and effective treatment modality for facial resurfacing.</p>","PeriodicalId":87690,"journal":{"name":"Medscape journal of medicine","volume":"10 7","pages":"155"},"PeriodicalIF":0.0000,"publicationDate":"2008-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2525463/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medscape journal of medicine","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To describe our experience with coblation technology for facial resurfacing
Methods: Retrospective chart review of all patients treated with coblation at our institution
Results: Twenty-four patients (22 female) underwent a total of 29 coblation procedures for aging face (n = 21) or acne scarring (n = 3). The perioral region was the most frequently treated aesthetic subunit (n = 14), followed by the lower eyelid (n = 7). Five patients underwent full-face coblation. Three patients underwent a second coblation procedure for aging face while a single patient with severe acne scarring underwent 3 procedures. Repeat coblation was delayed at least 5 months (mean, 9 months). Seventeen coblation procedures (59%) were performed concurrently with procedures including, but not limited to, injection treatment, rhinoplasty, blepharoplasty, or combined face/necklift; no adverse events occurred. Seven procedures, including a full-face coblation, were performed in the office under local anesthesia and oral sedation without any adverse events. Mean follow-up was 6 months (range, 1 week to 24 months). No complications were observed. All patients were satisfied with the results after their final coblation treatment.
Conclusions: Facial coblation is a safe and effective treatment modality for facial resurfacing.